glp-1 in body A new Science Perspective highlights the growing of evidence that hints at the potential of GLP-1–based medications treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders Glucagon-like peptide-1 receptors in the

The availability of endocrinologists, cardiologists, and obesity specialists supports widespread adoption of GLP-1 agonists

Treatments available in North Fulton include complex excision and reconstruction with microvascular free tissue transfers as well as CyberKnife radiation treatments

UHC Fraud Suit Signals States' Medicaid FCA Push Massachusetts' recently filed False Claims Act suit alleging UnitedHealthcare misrepresented the health status of enrollees in a Medicaid senior care organization plan it managed pushes forward a new phase of state-level scrutiny of managed care data and Medicaid payment mechanisms, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwendolyn Stamper at Vogel Slade

Accordingly, patient-reported complaints such as food tastes different, food is less enjoyable, or I no longer want to eat may reflect different points along this mediating chain: some may correspond to subjective value reappraisal under altered interoceptive states (5), whereas others may reflect reduced cue responsivity or motivational suppression arising from avoidance learning (5, 60)